Assessment of the Antileishmanial Potential of Cassia fistula Leaf Extract

Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, an...

Full description

Saved in:
Bibliographic Details
Published inACS omega Vol. 6; no. 3; pp. 2318 - 2327
Main Authors Tabrez, Shams, Rahman, Fazlur, Ali, Rahat, Alouffi, Abdulaziz S, Alshehri, Bader Mohammed, Alshammari, Fahdah Ayed, Alaidarous, Mohammed A, Banawas, Saeed, Bin Dukhyil, Abdul Aziz, Rub, Abdur
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 26.01.2021
Online AccessGet full text

Cover

Loading…
Abstract Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed in vitro antileishmanial and cytotoxicity assays. Methanolic extract of C. fistula leaves showed growth inhibition and proliferation of L. donovani promastigote with an IC50 value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC50 value of 80.76 ± 3.626 μg/mL. C. fistula extract was found cytotoxic at a very high concentration on human macrophages (CC50 = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by C. fistula to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of C. fistula leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity.
AbstractList Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase ( Ld SMT), trypanothione reductase ( Ld TR), pteridine reductase ( Ld PTR1), and nucleoside hydrolase ( Ld NH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed in vitro antileishmanial and cytotoxicity assays. Methanolic extract of C. fistula leaves showed growth inhibition and proliferation of L. donovani promastigote with an IC 50 value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC 50 value of 80.76 ± 3.626 μg/mL. C. fistula extract was found cytotoxic at a very high concentration on human macrophages (CC 50 = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by C. fistula to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of C. fistula leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity.
has a wide array of biologically active and therapeutically important class of compounds. important drug targets, sterol 24-c methyltransferase ( SMT), trypanothione reductase ( TR), pteridine reductase ( PTR1), and nucleoside hydrolase ( NH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed antileishmanial and cytotoxicity assays. Methanolic extract of leaves showed growth inhibition and proliferation of promastigote with an IC value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC value of 80.76 ± 3.626 μg/mL. extract was found cytotoxic at a very high concentration on human macrophages (CC = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity.
Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed in vitro antileishmanial and cytotoxicity assays. Methanolic extract of C. fistula leaves showed growth inhibition and proliferation of L. donovani promastigote with an IC50 value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC50 value of 80.76 ± 3.626 μg/mL. C. fistula extract was found cytotoxic at a very high concentration on human macrophages (CC50 = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by C. fistula to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of C. fistula leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity.
Author Alouffi, Abdulaziz S
Tabrez, Shams
Rub, Abdur
Ali, Rahat
Alshehri, Bader Mohammed
Alshammari, Fahdah Ayed
Bin Dukhyil, Abdul Aziz
Alaidarous, Mohammed A
Rahman, Fazlur
Banawas, Saeed
AuthorAffiliation Infection and Immunity Lab , Department of Biotechnology
Health and Basic Sciences Research Center
Department of Biomedical Sciences
Majmaah University
Oregon State University
College of Sciences and Literature Microbiology
Department of Medical Laboratory Sciences, College of Applied Medical Sciences
AuthorAffiliation_xml – name: Infection and Immunity Lab , Department of Biotechnology
– name: Department of Biomedical Sciences
– name: Oregon State University
– name: Health and Basic Sciences Research Center
– name: Department of Medical Laboratory Sciences, College of Applied Medical Sciences
– name: Majmaah University
– name: College of Sciences and Literature Microbiology
Author_xml – sequence: 1
  givenname: Shams
  surname: Tabrez
  fullname: Tabrez, Shams
  organization: Infection and Immunity Lab , Department of Biotechnology
– sequence: 2
  givenname: Fazlur
  surname: Rahman
  fullname: Rahman, Fazlur
  organization: Infection and Immunity Lab , Department of Biotechnology
– sequence: 3
  givenname: Rahat
  surname: Ali
  fullname: Ali, Rahat
  organization: Infection and Immunity Lab , Department of Biotechnology
– sequence: 4
  givenname: Abdulaziz S
  surname: Alouffi
  fullname: Alouffi, Abdulaziz S
– sequence: 5
  givenname: Bader Mohammed
  surname: Alshehri
  fullname: Alshehri, Bader Mohammed
  organization: Department of Medical Laboratory Sciences, College of Applied Medical Sciences
– sequence: 6
  givenname: Fahdah Ayed
  surname: Alshammari
  fullname: Alshammari, Fahdah Ayed
  organization: College of Sciences and Literature Microbiology
– sequence: 7
  givenname: Mohammed A
  surname: Alaidarous
  fullname: Alaidarous, Mohammed A
  organization: Majmaah University
– sequence: 8
  givenname: Saeed
  surname: Banawas
  fullname: Banawas, Saeed
  organization: Oregon State University
– sequence: 9
  givenname: Abdul Aziz
  surname: Bin Dukhyil
  fullname: Bin Dukhyil, Abdul Aziz
  organization: Majmaah University
– sequence: 10
  givenname: Abdur
  orcidid: 0000-0003-1301-0761
  surname: Rub
  fullname: Rub, Abdur
  email: arub@jmi.ac.in
  organization: Infection and Immunity Lab , Department of Biotechnology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33521470$$D View this record in MEDLINE/PubMed
BookMark eNp1kctOIzEQRS0E4hHYs0L9AQT87McGKYpgAEUaFrC2qt3lxFF3G9kOgr_HTADBYlYuue49Zdc9IrujH5GQU0YvGOXsEkz0Ay7hghqqSt7skEMuKzplQordH_UBOYlxTSllZc1rXu6TAyEUZ7l_SO5nMWKMA46p8LZIKyxmY3I9urgaYHTQFw8-5e5HlQVziNFBYV1Mmx6KBYItrl9TAJOOyZ6FPuLJ5zkhTzfXj_Pb6eLvn7v5bDEFqao0lRV01LRlrWorTWW54q3itm2VqlSDvKlFZduuBGOkFQhVLUUNaBpJS6ZEJSbkbsvtPKz1c3ADhDftwel_Fz4sNYTkTI-al6XNGOSmlZJhA0ZSbqCDhqFoGc2sqy3redMO2Jn80QD9L-jvzuhWeulfdH4Va_JyJ4RuASb4GAPaby-j-iMm_RWT_owpW85-zvw2fIWSBedbQbbqtd-EMa_z_7x3NTyh3g
CitedBy_id crossref_primary_10_1016_j_biopha_2021_112156
crossref_primary_10_1007_s11756_024_01656_y
crossref_primary_10_1002_jcb_29944
crossref_primary_10_1016_j_biopha_2021_112240
crossref_primary_10_1590_s2175_97902022e21306
crossref_primary_10_1002_ddr_21820
crossref_primary_10_3389_fphar_2022_953352
crossref_primary_10_1016_j_heliyon_2022_e10251
Cites_doi 10.1038/s41564-018-0154-2
10.1021/jm900185q
10.1093/cid/cis474
10.1016/j.vaccine.2009.02.079
10.1007/BF00228148
10.1023/A:1006784224191
10.1016/j.jss.2005.08.025
10.1002/jcb.26433
10.1002/jsfa.7578
10.1016/j.exppara.2008.05.005
10.1093/jmedent/30.4.699
10.1371/journal.pone.0035671
10.1186/1758-2946-3-33
10.1006/jmbi.1993.1626
10.1371/journal.pone.0221331
10.3389/fimmu.2014.00273
10.1042/BSR20201256
10.1111/mmi.14139
10.13172/2054-4057-1-1-1119
10.1007/978-1-4939-2269-7_19
10.1017/S0031182011001120
10.5962/bhl.title.137025
10.1021/ja00051a040
10.1371/journal.pntd.0002536
10.5530/pj.2011.26.11
10.1016/j.bjp.2018.04.013
10.1016/j.ijantimicag.2018.12.011
10.3389/fimmu.2014.00193
10.4103/2231-4040.79814
10.1093/nar/gkn860
10.1002/(SICI)1099-1573(199812)12:8<576::AID-PTR354>3.0.CO;2-#
10.4103/0974-8490.157956
10.3390/molecules22010058
10.1016/j.ijpara.2004.10.019
10.1002/jcc.21334
10.1002/9780470514009.ch2
10.3390/nu8020090
ContentType Journal Article
Copyright 2021 The Authors. Published by American Chemical Society
2021 The Authors. Published by American Chemical Society.
2021 The Authors. Published by American Chemical Society 2021 The Authors
Copyright_xml – notice: 2021 The Authors. Published by American Chemical Society
– notice: 2021 The Authors. Published by American Chemical Society.
– notice: 2021 The Authors. Published by American Chemical Society 2021 The Authors
DBID N~.
NPM
AAYXX
CITATION
5PM
DOA
DOI 10.1021/acsomega.0c05629
DatabaseName American Chemical Society (ACS) Open Access
PubMed
CrossRef
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
DatabaseTitleList
PubMed

Database_xml – sequence: 1
  dbid: N~.
  name: American Chemical Society (ACS) Open Access
  url: https://pubs.acs.org
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2470-1343
EndPage 2327
ExternalDocumentID oai_doaj_org_article_266fcc4e2cb441e9ac402cada91e3b10
10_1021_acsomega_0c05629
33521470
a665111763
Genre Journal Article
GroupedDBID 53G
ABUCX
ACS
ADACO
ADBBV
AFEFF
ALMA_UNASSIGNED_HOLDINGS
BCNDV
EBS
GROUPED_DOAJ
HYE
N~.
OK1
RPM
VF5
AAFWJ
AAHBH
AFPKN
AOIJS
M~E
NPM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-a457t-47ad0cb6858f4c7f252b52fbb55759e29837fbd6acc4f3ea78438aec940615373
IEDL.DBID RPM
ISSN 2470-1343
IngestDate Fri Oct 04 13:12:35 EDT 2024
Tue Sep 17 21:11:39 EDT 2024
Fri Aug 23 03:39:56 EDT 2024
Sat Sep 28 08:26:05 EDT 2024
Thu Jan 28 04:14:15 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License 2021 The Authors. Published by American Chemical Society.
This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a457t-47ad0cb6858f4c7f252b52fbb55759e29837fbd6acc4f3ea78438aec940615373
ORCID 0000-0003-1301-0761
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841934/
PMID 33521470
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_266fcc4e2cb441e9ac402cada91e3b10
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7841934
crossref_primary_10_1021_acsomega_0c05629
pubmed_primary_33521470
acs_journals_10_1021_acsomega_0c05629
ProviderPackageCode ACS
ABUCX
AFEFF
VF5
N~.
PublicationCentury 2000
PublicationDate 2021-01-26
PublicationDateYYYYMMDD 2021-01-26
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-26
  day: 26
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS omega
PublicationTitleAlternate ACS Omega
PublicationYear 2021
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
Thirumal M. (ref13/cit13) 2012; 1
Castro-Lopez C. (ref15/cit15) 2018; 3
ref6/cit6
ref3/cit3
ref18/cit18
Rappé A. K. (ref36/cit36) 1992; 114
ref25/cit25
ref16/cit16
ref29/cit29
Kumar K. (ref12/cit12) 2017; 3
ref32/cit32
ref23/cit23
ref39/cit39
ref14/cit14
Khan I. (ref43/cit43) 2005
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
Searo W. (ref4/cit4) 2005
ref34/cit34
ref37/cit37
ref40/cit40
ref20/cit20
Vasudevan D. T. (ref11/cit11) 2009; 7
ref10/cit10
ref26/cit26
Monzote L. (ref17/cit17) 2016; 10
ref35/cit35
ref19/cit19
ref21/cit21
Trott O. (ref28/cit28) 2010; 31
ref42/cit42
Dallakyan S. (ref27/cit27) 2015; 1263
ref41/cit41
ref22/cit22
ref33/cit33
ref30/cit30
ref1/cit1
ref24/cit24
ref38/cit38
ref44/cit44
ref7/cit7
References_xml – ident: ref1/cit1
  doi: 10.1038/s41564-018-0154-2
– ident: ref23/cit23
  doi: 10.1021/jm900185q
– ident: ref5/cit5
  doi: 10.1093/cid/cis474
– ident: ref25/cit25
  doi: 10.1016/j.vaccine.2009.02.079
– ident: ref32/cit32
  doi: 10.1007/BF00228148
– ident: ref9/cit9
  doi: 10.1023/A:1006784224191
– ident: ref14/cit14
  doi: 10.1016/j.jss.2005.08.025
– ident: ref34/cit34
  doi: 10.1002/jcb.26433
– volume-title: Medicinal and Aromatic Plants of India
  year: 2005
  ident: ref43/cit43
  contributor:
    fullname: Khan I.
– ident: ref16/cit16
  doi: 10.1002/jsfa.7578
– ident: ref22/cit22
  doi: 10.1016/j.exppara.2008.05.005
– ident: ref2/cit2
  doi: 10.1093/jmedent/30.4.699
– ident: ref3/cit3
  doi: 10.1371/journal.pone.0035671
– ident: ref35/cit35
  doi: 10.1186/1758-2946-3-33
– ident: ref31/cit31
  doi: 10.1006/jmbi.1993.1626
– ident: ref37/cit37
  doi: 10.1371/journal.pone.0221331
– volume: 3
  start-page: 38
  year: 2017
  ident: ref12/cit12
  publication-title: Int. J. Pharm. Chem. Res.
  contributor:
    fullname: Kumar K.
– volume: 1
  start-page: 43
  year: 2012
  ident: ref13/cit13
  publication-title: Crit. Rev. Pharm. Sci.
  contributor:
    fullname: Thirumal M.
– ident: ref26/cit26
  doi: 10.3389/fimmu.2014.00273
– ident: ref29/cit29
  doi: 10.1042/BSR20201256
– ident: ref24/cit24
  doi: 10.1111/mmi.14139
– ident: ref38/cit38
  doi: 10.13172/2054-4057-1-1-1119
– volume: 1263
  start-page: 243
  year: 2015
  ident: ref27/cit27
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-2269-7_19
  contributor:
    fullname: Dallakyan S.
– ident: ref7/cit7
  doi: 10.1017/S0031182011001120
– volume: 7
  start-page: 2363
  year: 2009
  ident: ref11/cit11
  publication-title: Int. J. Chem. Sci.
  contributor:
    fullname: Vasudevan D. T.
– ident: ref42/cit42
  doi: 10.5962/bhl.title.137025
– volume: 114
  start-page: 10024
  year: 1992
  ident: ref36/cit36
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00051a040
  contributor:
    fullname: Rappé A. K.
– ident: ref6/cit6
  doi: 10.1371/journal.pntd.0002536
– ident: ref44/cit44
  doi: 10.5530/pj.2011.26.11
– ident: ref18/cit18
  doi: 10.1016/j.bjp.2018.04.013
– volume-title: Regional Strategic Framework for Elimination of Kala-azar from South-East Asia Region (2005–2015)
  year: 2005
  ident: ref4/cit4
  contributor:
    fullname: Searo W.
– volume: 10
  start-page: 269
  year: 2016
  ident: ref17/cit17
  publication-title: Rec. Nat. Prod.
  contributor:
    fullname: Monzote L.
– ident: ref30/cit30
  doi: 10.1016/j.ijantimicag.2018.12.011
– ident: ref40/cit40
  doi: 10.3389/fimmu.2014.00193
– ident: ref10/cit10
  doi: 10.4103/2231-4040.79814
– ident: ref33/cit33
  doi: 10.1093/nar/gkn860
– volume: 3
  start-page: 1477
  year: 2018
  ident: ref15/cit15
  publication-title: Clin. Oncol.
  contributor:
    fullname: Castro-Lopez C.
– ident: ref41/cit41
  doi: 10.1002/(SICI)1099-1573(199812)12:8<576::AID-PTR354>3.0.CO;2-#
– ident: ref8/cit8
  doi: 10.4103/0974-8490.157956
– ident: ref21/cit21
  doi: 10.3390/molecules22010058
– ident: ref20/cit20
  doi: 10.1016/j.ijpara.2004.10.019
– volume: 31
  start-page: 455
  year: 2010
  ident: ref28/cit28
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.21334
  contributor:
    fullname: Trott O.
– ident: ref39/cit39
  doi: 10.1002/9780470514009.ch2
– ident: ref19/cit19
  doi: 10.3390/nu8020090
SSID ssj0001682826
Score 2.2513418
Snippet Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol...
has a wide array of biologically active and therapeutically important class of compounds. important drug targets, sterol 24-c methyltransferase ( SMT),...
Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol...
SourceID doaj
pubmedcentral
crossref
pubmed
acs
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2318
SummonAdditionalLinks – databaseName: ACS Journals
  dbid: ACS
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELbYcti98NxHl4dygAOHdBPbefhYqlZVBQgJKvUWjR3PbgWbrEgqIX79jtP0ERah3qLETvwYZ77xjL9h7B23cYhagp-mggyUVKU-2BR9RMIaqA2aZh_y85d4OpezRbTY0eT87cHn4RWYqry11zAIjFPW6og95i6A0MGg0bfdfkpMtkOTXY3LJPBDIUXrlfzXS5wuMlVHFzWU_Xt6qBsjuad0Jk_X2YuqhqvQxZr8GKxqPTB_HjI5HtCfZ-xJiz294VpYnrNHtnjBjkeblG8v2Wy45en0SvQIG3rDoqb_xrK6cTwZVPlrWbv4IrqiAiNC3kvwkKqvfoL3yQJ649-1O3h1yuaT8ffR1G-TLfggo6T2ZQJ5YLSjo0dpEuQR1xFHrSOXwtNyRZYs6jwGYyQKC0kqRQrWKIcIIpGIM9YrysJeMI_nGhU3kEsBZFBJneQWlIrQiIDbQPbZexqErF0sVdb4wXmYbUYma0emzz5spie7W3Nv_KfsRzd_23KONbu5QUOftYswIzCC1HzLjSYUaBUYsp6pnaBCK3QY9Nn5etK3r3En0kKSpz5LOuLQ-U73SbG8aVi6nUNXCXl5YGdfsRPuwmWC0Ofxa9arf63sG8I7tX7bCPo92Dj9Bw
  priority: 102
  providerName: American Chemical Society
– databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELZQF1gQb8pLGWBgCCS28_BYKqqqAsRAJbbo7PhoJUgRTSV-PuckrZoFFrYosRPrO0ffnX3-jrFLbuMQtQQ_TQUFKKlKfbAp-ojka6A2aKp1yMeneDiWo9foda3Ul8sJq-WBa-BuiUDQGGm50cTcVoGhiMdADiq0QjeHq8JoLZiqVldiiiT4cl-SeOwWzHz2Yd_gJjCO85VjIzNvsVEl2r_GRO0syTXaGeyw7cZf9Hr1OHfZhi322GZ_WaZtn416K21Nb4Ye-XNeryjpX5_OJ07bgjo_z0qXE0RX1KBP3vIUPKTui3fwHiygd_9dusNSB2w8uH_pD_2mQIIPMkpKXyaQB0Y7CXmUJkEecR1x1DpyZTctVxR9os5jIABRWEhSKVKwRjkWj0QiDlmnmBX2mHk816gcrlIABUFSJ7kFpSI0IuA2kF12RXBlzQSfZ9XeNQ-zJaxZA2uXXS8BzT5rvYxf2t45xFftnNJ1dYPsnzX2z_6yf5cd1WZavcadIgtlQk-SlgFb32k_KaaTSlnbbcIqIU_-Y2CnbIu7_Jcg9Hl8xjrl18KekwNT6otqrv4AwXjx3g
  priority: 102
  providerName: Directory of Open Access Journals
Title Assessment of the Antileishmanial Potential of Cassia fistula Leaf Extract
URI http://dx.doi.org/10.1021/acsomega.0c05629
https://www.ncbi.nlm.nih.gov/pubmed/33521470
https://pubmed.ncbi.nlm.nih.gov/PMC7841934
https://doaj.org/article/266fcc4e2cb441e9ac402cada91e3b10
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZYLu0Flb5YWlY5tAcO2U1s5-HjEoEQKgipIHGLxo4HVmITxAapJ347Y2-y2lw49BJFsZ1YMxPNN_b4G8Z-cZvGqCWEeS4oQMlVHoLNMUQkrIHaoPHrkJdX6fmtvLhL7nZY0p-F8Un7Ri-m9eNyWi8efG7l09LM-jyx2fVl4fbKlJCzERtlQmyF6H5hJaUggvdbkuTCZmBWzdLewzQyzt07olB30iiWrkLxiFoHPslT92_5o2Gu5JbzOfvE9jrUGMzXs9tnO7b-zD4UfbG2L-xivmHYDBoMCNUF87qlP36xenAMFzT4umldZhDdUYeCMPMCAqThL48Q_LGAwem_1h2Z-spuz05vivOwK5MQgkyyNpQZVJHRjkgepcmQJ1wnHLVOXPFNyxXFoKirFIyRKCyQ9EQO1ijnyxORiW9st25qe8ACXmlU3EAlBVAoJHVWWVAqQSMibiM5Zr9JXGVn5qvS72DzuOwlXHYSHrPjXqDl05o1452-J07im36O79o_aJ7vy07rJcEIpOlbbjThN6vAUNxL8wQVW6HjaMy-r9W0eU2v4THLBgocfGfYQubm-bU78zr875E_2EfuUl-iOOTpT7bbPr_YI8IurZ4Qdi_-TnzkT9er1-nEW-8b4zj0WA
link.rule.ids 230,315,733,786,790,870,891,2115,2782,27109,27113,27957,27958,53827,53829,57093,57117,57143,57167
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PT9swFH5icGCXAftZGJDDdtghXWI7dXzsKlBhBU0bSNwi2_GDals6Lak07a_n2U0LmSa03SLHduzn57zv2c-fAd4wN0jRCB3nOScHJVd5rF2OMSJhDTQWbViHPDsfjC_F6VV2tQbp8iwMNaKmmuqwiX_HLpC-p7TZd3et-4n1Nls9go1Mkjvu0dDoy92yyoBciHDJGhMyiVMueLs5-bdKvEmydcckBeb-e-aoGyp5z_Ycb8HnVatDyMnX_rwxffv7D0LH_-rWNjxpkWg0XKjODqy56ilsjpYXwD2D0-GKtTOaYURIMRpWDf1FpvWNZ82gwp9mjY82oifKMCIcPtURUvH5Nx1NnMbo6Ffjj2E9h8vjo4vROG6vXoi1yGQTC6nLxBpPTo_CSmQZMxlDYzJ_oadjivxaNOVAWyuQOy1zwXPtrPL4IOOSv4D1ala5VxCx0qBiVpeCa3KvhJGl00plaHnCXCJ68JaEULRTpy7CrjhLi6VkilYyPXi3HKXix4KJ44G8H_wwrvJ5Du2QQOIv2ilZEDRBar5j1hAmdEpb8qWpnVqljps06cHLxdivqvHn01JSqx7IjlZ0vtN9U01vAme3395VXOz-Y2cPYXN8cTYpJifnH_fgMfOBNImPPXwN683PudsnJNSYg6D7t3OqBXo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIkEvUF7tAoUc4MAh28SPJD4u265KKVUlKOotsh0PXbXNViQrIX49Y292aSqE4BY5tmN77Mw3HvsbgDfMZSkaoeOi4GSgFKqItSswRiSsgcaiDfuQn46zg1NxeCbP1kAu78JQIxqqqQlOfL-qryvsGAbSXUqfXblvephYr7fVHbgrffxuj4jGn39vrWRkRoRAa0zkSZxywTsH5Z8q8WrJNj21FNj7b6ik_nHJG_pn8hC-rloejp1cDOetGdqft0gd_7trm_CgQ6TRaDGFHsGaqx_D_fEyENwTOByt2DujGUaEGKNR3dLfZNqce_YMKnwya_2pI3qiDGPC41MdIRWfX-royGmM9n-0_jrWUzid7H8ZH8RdCIZYC5m3sch1lVjjSepR2ByZZEYyNEb6wJ6OKbJv0VSZtlYgdzovBC-0s8rjBMlz_gzW61nttiFilUHFrK4E12RmCZNXTisl0fKEuUQM4C0NQtktoaYM3nGWlsuRKbuRGcC7paTK6wUjx1_yvveiXOXzXNohgURQdkuzJIiC1HzHrCFs6JS2ZFNTO7VKHTdpMoCthfxX1fh7ailNrQHkvZnR-07_TT09D9zd3s2ruHj-j519DfdO9ibl0Yfjjy9gg_nzNEkas-wlrLff526HAFFrXoXp_wu74Qf7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+Antileishmanial+Potential+of+Cassia+fistula+Leaf+Extract&rft.jtitle=ACS+omega&rft.au=Tabrez%2C+Shams&rft.au=Rahman%2C+Fazlur&rft.au=Ali%2C+Rahat&rft.au=Alouffi%2C+Abdulaziz+S&rft.date=2021-01-26&rft.eissn=2470-1343&rft.volume=6&rft.issue=3&rft.spage=2318&rft_id=info:doi/10.1021%2Facsomega.0c05629&rft_id=info%3Apmid%2F33521470&rft.externalDocID=33521470
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon